Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
Clinical trial NCT01821963 · TERMINATED
Trial details
- NCT number
- NCT01821963
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.